Chargement en cours...

Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?

The need for new acid suppressing agents with improved pharmacology and superior antisecretory effects to address unmet clinical needs in acid-related disorders has been evident for over a decade. Recent new antisecretory drugs (IR-omeprazole and MR-dexlansoprazole) only provide a small incremental...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Transl Gastroenterol
Auteurs principaux: Hunt, Richard H, Scarpignato, Carmelo
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4816037/
https://ncbi.nlm.nih.gov/pubmed/26513137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ctg.2015.39
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!